These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16517966)

  • 21. The effect of glucagon on FDG uptake in skeletal muscle.
    Yasuda S; Takechi M; Ono M; Miyatake Y; Itoh M; Kojima T; Ko W; Ushimi T; Kobayashi K
    Tokai J Exp Clin Med; 2012 Apr; 37(1):11-3. PubMed ID: 22488557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Toxicity and radiation dosage of 2-(18F)-2-desoxy-D-glucose in positron emission tomography].
    Ruhlmann J; Oehr P; Bender H; Kozak B; Willkomm P; Bechtold V; Lind P; Biersack HJ
    Acta Med Austriaca; 1998; 25(1):1-6. PubMed ID: 9576017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal variants in [18F]-fluorodeoxyglucose PET imaging.
    El-Haddad G; Alavi A; Mavi A; Bural G; Zhuang H
    Radiol Clin North Am; 2004 Nov; 42(6):1063-81, viii. PubMed ID: 15488558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treadmill exercise inducing mild to moderate ischemia has no significant effect on skeletal muscle or cardiac 18F-FDG uptake and image quality on subsequent whole-body PET scan.
    Lyall A; Capobianco J; Strauss HW; Gonen M; Schöder H
    J Nucl Med; 2012 Jun; 53(6):917-21. PubMed ID: 22586146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-body PET/CT studies with lowered ¹⁸F-FDG doses: the influence of body mass index in dose reduction.
    Sánchez-Jurado R; Devis M; Sanz R; Aguilar JE; del Puig Cózar M; Ferrer-Rebolleda J
    J Nucl Med Technol; 2014 Mar; 42(1):62-7. PubMed ID: 24503348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities.
    Kawata S; Imaizumi M; Kako Y; Oku N
    Ann Nucl Med; 2014 May; 28(4):322-8. PubMed ID: 24488705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing injected dose in clinical PET by accurately modeling the counting-rate response functions specific to individual patient scans.
    Watson CC; Casey ME; Bendriem B; Carney JP; Townsend DW; Eberl S; Meikle S; Difilippo FP
    J Nucl Med; 2005 Nov; 46(11):1825-34. PubMed ID: 16269596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence, challenges, and solutions for (18)F-FDG PET studies of obese patients: a technologist's perspective.
    Botkin CD; Osman MM
    J Nucl Med Technol; 2007 Jun; 35(2):80-3. PubMed ID: 17496007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for extensive skeletal muscle uptake in oncologic FDG-PET/CT for patients undergoing a 4-h fast.
    Nakatani K; Nakamoto Y; Togashi K
    Nucl Med Commun; 2012 Jun; 33(6):648-55. PubMed ID: 22395030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Variations of the hepatic SUV in relation to the body mass index in whole body PET-CT studies].
    Batallés SM; Villavicencio RL; Quaranta A; Burgos L; Trezzo S; Staffieri R; Pezzotto SM
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):26-32. PubMed ID: 23177341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation for performing ¹¹C-methionine and ¹⁸F-FDG-PET studies on the same day.
    Mitsumoto T; Kubota K; Sato T; Morooka M; Minamimoto R; Shimbo T; Muramatsu Y; Sasaki T; Ito K; Fukushi M
    Nucl Med Commun; 2012 Mar; 33(3):297-304. PubMed ID: 22107999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of organ-specific glucose metabolism by ¹⁸F-FDG in insulin receptor substrate-1 (IRS-1) knockout mice as a model of insulin resistance.
    Cheng C; Nakamura A; Minamimoto R; Shinoda K; Tateishi U; Goto A; Kadowaki T; Terauchi Y; Inoue T
    Ann Nucl Med; 2011 Dec; 25(10):755-61. PubMed ID: 21818569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing physiological FDG uptake in the intestine.
    Yasuda S; Takahashi W; Takagi S; Fujii H; Ide M; Shohtsu A
    Tokai J Exp Clin Med; 1998 Nov; 23(5):241-4. PubMed ID: 10418728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation methods prior to PET/CT scanning that decrease uptake of 18F-FDG by myocardium, brown adipose tissue, and skeletal muscle.
    Shao D; Tian XW; Gao Q; Liang CH; Wang SX
    Acta Radiol; 2017 Jan; 58(1):10-18. PubMed ID: 26936898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium.
    Madar I; Ravert HT; Du Y; Hilton J; Volokh L; Dannals RF; Frost JJ; Hare JM
    J Nucl Med; 2006 Aug; 47(8):1359-66. PubMed ID: 16883017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo measurements of glucose uptake in human Achilles tendon during different exercise intensities.
    Hannukainen J; Kalliokoski KK; Nuutila P; Fujimoto T; Kemppainen J; Viljanen T; Laaksonen MS; Parkkola R; Knuuti J; Kjaer M
    Int J Sports Med; 2005 Nov; 26(9):727-31. PubMed ID: 16237617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-body 18F-FDG PET/CT: the need for a standardized field of view--a referring-physician aid.
    Huston SF; Abdelmalik AG; Nguyen NC; Farghaly HR; Osman MM
    J Nucl Med Technol; 2010 Sep; 38(3):123-7. PubMed ID: 20724533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Treadmill exercise does not affect image quality on subsequent whole body FDG PET scan".
    Spirnak J
    J Nucl Med; 2011 Dec; 52(12):2020. PubMed ID: 22068896
    [No Abstract]   [Full Text] [Related]  

  • 39. Methodological aspects of multicenter studies with quantitative PET.
    Boellaard R
    Methods Mol Biol; 2011; 727():335-49. PubMed ID: 21331942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG imaging: pitfalls and artifacts.
    Abouzied MM; Crawford ES; Nabi HA
    J Nucl Med Technol; 2005 Sep; 33(3):145-55; quiz 162-3. PubMed ID: 16145222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.